Mereo Biopharma Share Discussion Threads

[ny boy] 31/12/2019 12:10

Usual holiday nutty trading lol

31.2 is the pivotal point, buying will resume soon after the holidays imo

[dave4545] 31/12/2019 11:16

1 million % except you mean Friday :-))

This is clearly a mm stock, happy to mop up all the idiots selling around 30p but not let anybody buy until they hike the offer back to 35p+

Very profitable for them, very hard for pi's to make money so I'll pass for now, would have paid 30-32p for stock but never got that low

[sapper2476] 31/12/2019 11:00

Why on earth would you sell 28k at 30p when you could sell for 50p yesterday. People never cease to amaze me.

[sapper2476] 31/12/2019 10:52

Wow. Another one.

[ny boy] 31/12/2019 09:56

Nice pull back playing out on holiday vols!

[ny boy] 31/12/2019 08:29

More opportunities in thin holiday trading to go shopping for some late bargains before the new decade of immense opportunities, TWD & FOXT, MSYS, NFX also on my list.

[sapper2476] 31/12/2019 05:41

I might add that there is serious lack of shares in circulation. With major holders plus directors I estimate under 30m.

[sapper2476] 31/12/2019 05:40

Usual profit taking after it failed to run again and people can’t hold for ten minutes. News will drive

[harleymaxwell] 30/12/2019 22:12

So what's the view - profit taking or a false dawn ?Prices seem to fluctuate per trade . Any Chartists have a view?Cheers

[babbler] 30/12/2019 12:49

So today or tomorrow

[diversification] 30/12/2019 12:25

This year, Pfizer invested $810m with an upfront $340m payment for a Phase I drug referred to by Mereo in their corporate presentation. With a similar deal done by Ipsen for a Phase III drug for $1,303 with a $1,040 upfront payment. It gives you a strong indication as to how valuable these bone drugs can be, with Norvartis strongly tied to our company for obvious reasons. However it's the six month data for the Phase II MPH966 that is due by or around year end.

[leedslad001] 30/12/2019 10:33

Pull back to be expected after the large rise profit taking nothing wrong with that

[iamgreat1] 30/12/2019 10:24

Back down we go

[showmethemoneyhoney01] 30/12/2019 10:03

Very worthwhile listen. Need a £30m funding partner to take the brittle bone drug to final testing. Talking to multiple partners who ‘ understand’ the data. This will fly on announcement. I’m holding most for the results in 2 years time. Could 10-20 bag on success. Let's see who partners them and in what terms.

[babbler] 30/12/2019 09:08

Was NT to buy most the first 10 mins then they opened it at 54.7. Now seller around they dropped it..Highly tempting.

[sapper2476] 30/12/2019 08:59

I am seriously mulling over a large buy.

[babbler] 30/12/2019 08:58

Time to take advantage of the lull perhaps

[ny boy] 30/12/2019 08:19

This one, already paid for my trip to Asia for a few months to escape the blighty winter.

Another one brewing for a 2020 outperform is (MSYS), certainly one to tuck away imo

[showmethemoneyhoney01] 30/12/2019 08:11

Post as much research as you want. Got just under 15,000 shares in 2 lots.

[showmethemoneyhoney01] 29/12/2019 20:52

Wish people would stop posting it as I want in first thing for more.

[leedslad001] 29/12/2019 20:50

Thanks for the info

[hope67] 29/12/2019 19:26

Watch this

[hope67] 28/12/2019 21:40

listen from 7mins

[diversification] 27/12/2019 20:18

13th December 2019 - Corporate presentationPage 24. It provides an indiction as to how valuable a Phase II completed trial could be and could range between $810m and $1303m with a significant upfront payment. A commercial partner that will help fund phase III as per the most recent communication from the company.This is what we should be keeping on our toes for. https://www.mereobiopharma.com/media/1414/investor-meetings-december-2019.pdf